Results 191 to 200 of about 192,585 (246)

DNMT3A mutations are unlikely to affect interferon alfa treatment outcomes in patients with polycythemia vera. [PDF]

open access: yesBlood
Abu-Zeinah G   +8 more
europepmc   +1 more source

Tumor Integrin-Targeted Glucose Oxidase Enzyme Promotes ROS-Mediated Cell Death that Combines with Interferon Alpha Therapy for Tumor Control. [PDF]

open access: yesMol Cancer Ther
Stinson JA   +8 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

PSORIASIS AND ALPHA-INTERFERON

Lancet, The, 1986
Two patients with metastatic renal carcinoma who were treated with recombinant-DNA-derived alpha-interferon (rIFN alpha) had exacerbation of concomitant psoriasis, and another patient experienced onset of psoriasis during treatment with rIFN alpha. This suggests that interferons may participate in the pathophysiology of psoriasis.
J R Quesada, J U Gutterman
exaly   +3 more sources

Interferon-alpha hybrids

Pharmacology & Therapeutics, 1995
The alpha-interferons (IFN-alpha) belong to a family of polypeptides comprising several subtypes. Using recombinant DNA technology, it has been possible to create IFN hybrids that provide novel combinations of the amino acid residues from the parental protein sequences.
M A, Horisberger, S, Di Marco
openaire   +2 more sources

The New Alpha Interferons

Drug Intelligence & Clinical Pharmacy, 1985
Alpha interferons are biological response modifiers that regulate immune function, slow cell proliferation, and inhibit virus replication. Large supplies of purified preparations are now available for clinical trials. Common toxicity includes an influenza-like syndrome to which tolerance occurs after several doses, and chronic fatigue and anorexia that
Carol McManus Balmer, Donald C. McLeod
openaire   +2 more sources

Home - About - Disclaimer - Privacy